The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions-Reference-Cited by-同舟云学术

The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions

Published:2024-08-06 Issue:5 Volume:49 Page:631-644
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Patil Prajakta Harish,Desai Mrunal,Birangal Sumit,Gurupur Gautham Shenoy,Rao Mahadev,Yadav Anandkumar,Kurawattimath Vishwanath,Chaudhari Avinash,Sharma Tarun,Pinjari Jakir,Channabasavaiah Jagadish Puralae^ORCID

Funder

Indian Council of Medical Research

Manipal Academy of Higher Education, Manipal

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13318-024-00909-0.pdf

Reference32 articles.

1. Zhang M, Zhang L, Hei R, Li X, Cai H, Wu X, et al. CDK inhibitors in cancer therapy, an overview of recent development. Am J Cancer Res. 2021;11:1913–35.

2. Hecht KA, Selby C. Review of cyclin-dependent kinase 4/6 inhibitors for the treatment of hormone receptor-positive advanced breast cancer. Ann Pharmacother. 2019;53:195–203.

3. Mughal MJ, Bhadresha K, Kwok HF. CDK inhibitors from past to present: a new wave of cancer therapy. Semin Cancer Biol. 2023;88:106–22.

4. Adon T, Shanmugarajan D, Kumar HY. CDK4/6 inhibitors: a brief overview and prospective research directions. RSC Adv. 2021;11:29227–46.

5. Shohdy KS, Lasheen S, Kassem L, Abdel-Rahman O. Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis. Ther Adv Drug Saf. 2017;8:337–47.